NR2F2 / COUP transcription factor 2 · Western blot design guide

Design a Western Blot for NR2F2

Real validated NR2F2 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-NR2F2 WB antibodies. Everything you need to plan the experiment before you commit precious samples.

Evidence assembled September 2026 · For research use; verify linked source records and product datasheet before use
Western blot protocol sheet for NR2F2: expected band ~45.6 kDa, hero antibody A02420T7, catalog values and labelled standard workflow; separate PMC comparisons on the guide
Printable NR2F2 Western blot protocol sheet — expected band ~45.6 kDa, antibody A02420T7, controls and PMC citations. Open the full NR2F2 WB guide →

NR2F2 Western Blot Experimental Design Guide

Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band ~45.6 kDa
Gel 12–15% (standard starting point)
Negative control ⓘ Suggested KO / knockdown lysate
Important caveats
Reasons your observed band may differ from the expected size.
PTM Phosphorylated
Caveat Phosphorylation-state controls
Gene-set association MSigDB C7 membership
Isoform 3 isoform(s)
Section 1

Real Curated NR2F2 Western Blot Protocols

The A02420T7 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.

Recommended Western blot protocol parameters
Sample / lysateMCF-7 (40ug), HEK293T (20ug), H9C2 (20ug) (catalog A02420T7)
Gel %12–15% (standard starting point)
Load20–30 µg total protein per lane; optimize for abundance (standard starting point)
TransferStandard semi-dry transfer; verify efficiency (standard starting point)
Membrane0.45 µm PVDF (standard starting point)
Blocking5% milk or 5% BSA in TBST (standard starting point)
Primary antibodyA02420T7; use the WB datasheet starting dilution (standard starting point)
Primary incubationOvernight at 4 °C (standard starting point)
Secondary antibodySpecies-matched HRP conjugate at validated dilution (standard starting point)
Secondary incubation1 h at room temperature (standard starting point)
Wash3 × 5 min in TBST (standard starting point)
DetectionECL; bracket exposures to avoid saturation (standard starting point)
Section 2

What Is the Expected NR2F2 Western Blot Band Size?

NR2F2 is predicted at 45.6 kDa; isoforms and Thr51 phosphorylation are annotated, but their effects on band migration have not been demonstrated.

What am I looking at on my blot?
Band near 45.6 kDaConsistent with predicted NR2F2 mass; confirm identity with a depletion control
Several bands at different positionsIsoforms 1, 2 and 3 are annotated, but distinct migration is unproven
Single band despite three annotated isoformsThe isoforms may be unresolved or not all detected
Band offset from 45.6 kDaThr51 phosphorylation is annotated, but its migration effect is unknown
💡Expected NR2F2 appearanceNR2F2 has a predicted mass of 45.6 kDa; no empirical band is supplied, so assess any band near that size with molecular weight markers and an NR2F2 depletion control.
How each factor affects band size
UniProt predicted massSets a 45.6 kDa reference for NR2F2
Splice isoform 1May migrate differently from other isoforms; its size is unspecified
Splice isoform 2May migrate differently from other isoforms; its size is unspecified
Splice isoform 3May migrate differently from other isoforms; its size is unspecified
Why is my band missing or off?
SituationLikely causeNext action
No band in lysateNR2F2 is nuclear and may be poorly recoveredCheck nuclear enrichment and lysate recovery
Band higher than expectedThe migration difference is unassigned by the supplied featuresCheck molecular weight markers and test NR2F2 depletion
Band lower than expectedThe migration difference is unassigned; isoform sizes are unspecifiedTest NR2F2 depletion and compare antibody recognition of isoforms
Multiple bandsThree splice isoforms are annotated, but band identities are unconfirmedUse NR2F2 depletion to identify specific bands
Weak or no signalA nuclear target may be diluted in whole-cell lysateCheck nuclear enrichment and include a positive control lysate

Sample controls for NR2F2 Western blot

🧪For positive controls for NR2F2 in Western blot, you can use a validated NR2F2-expressing sample once identified, since the supplied HPA record lists no positive candidate.
Positive control: No high/medium HPA tissue identified
Negative control: Suggested KO / knockdown lysate
Loading controls: Run GAPDH, β-actin, and a total-protein stain alongside the samples.
⚠️Feasibility: NR2F2 is nuclear, but the supplied HPA record has no tissue data to establish positive or negative controls.

HPA tissue expression evidence for NR2F2

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Higher expression tissues · candidate positive controls from IHC

TissueCell typeLevelEvidenceSource
No high/medium HPA tissues identified in the supplied evidence.

Lower expression tissues · IHC evidence, not confirmed WB-negative controls

TissueCell typeLevelEvidenceSource
No lower-expression tissue rows available in the supplied evidence.
Section 3

Advanced NR2F2 Western Blot Tips

Deeper troubleshooting and optimisation questions for NR2F2, answered from its protein features.

How should NR2F2 band migration be interpreted?
Band shift · Use the separately labelled calculated mass and catalog-observed evidence above. A sequence annotation does not establish an observed migration shift. Verify target identity with orthogonal controls.
Could NR2F2 isoforms produce different bands?
Isoforms · UniProt lists isoforms 1, 2 and 3. Isoform 3 lacks canonical residues 1–153; isoform 2 replaces residues 1–147 with a different sequence. Their sequence differences could affect migration, but the supplied features do not establish which bands are visible.

Check the antibody epitope against the isoform sequences. An epitope within canonical residues 1–153 is absent from isoform 3; one within residues 1–147 may also be altered in isoform 2. An antibody against an unchanged region is better suited to comparing the listed isoforms.
Can phosphorylation explain an NR2F2 band shift?
PTM · UniProt lists phosphothreonine at canonical residue 51. That residue lies in the region missing from isoform 3 and replaced in isoform 2. Use canonical UniProt numbering when comparing site claims. The listed modification alone does not establish a visible shift or explain any apparent mass difference.
Does this guide establish induction of NR2F2?
Induction · No general induction response is established by this guide. A pathway or gene-set association is not evidence of induction in a particular specimen. Verify the relevant treatment and control in a target-specific experiment.
How should transfer be checked for NR2F2?
Transfer · Standard workflow guidance: verify transfer efficiency for the intended target size before interpreting a weak signal. Use total-protein assessment and optimize transfer for the membrane, gel and apparatus; the labelled catalog values take precedence.
How should blocking be optimized?
Blocking · Standard workflow guidance: follow the A02420T7 datasheet where specified. Otherwise compare 5% milk or 5% BSA in TBST; for a phospho-specific assay start with BSA. Optimize background and specific signal with matched controls.
What should be kept consistent when quantifying NR2F2?
Quantitation · NR2F2 is listed in the nucleus, so use the same sample fraction across comparisons. Record which isoforms the antibody can detect before combining bands in one measurement. If measuring phosphorylation, distinguish a phosphothreonine 51 signal from total NR2F2 and specify that residue numbering refers to the canonical UniProt sequence.
Should NR2F2 migrate at its predicted 45.6 kDa?
Interpretation · 45.6 kDa is the predicted mass of canonical NR2F2. No observed band position is supplied, so a difference between apparent and predicted mass cannot be established. Use 45.6 kDa as a reference, not a required migration position.

First compare the antibody epitope with the three listed isoforms and their altered N-terminal sequences. NR2F2 binds DNA as a homodimer or with NR2F6 and interacts with other proteins, but those features do not establish that a higher band is a stable complex on a Western blot. Band identity needs independent validation.
Boster reagents

NR2F2 Western Blot Antibodies

Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.

Real WB data Western blot (WB) analysis of ARP-1 (T7) pAb at 1:500 dilution Lane1:MCF-7 whole cell lysate(40ug) Lane2:HEK293T whole cell lysate(20ug) Lane3:H9C2 whole cell lysate(20ug) Lane4:MEF whole cell lysate(40ug)
Anti-ARP-1 (T7) NR2F2 Antibody
Cat # A02420T7
Real WB data <h4>Western blotting validation for Anti-ARP-1 NR2F2 Antibody A02420-1</h4> Western Blot (WB) analysis of specific cells using ARP-1 polyclonal antibody. Electrophoresis was performed on a SDS-PAGE gel. To determine SDS-PAGE gel concentration
Anti-ARP-1 NR2F2 Antibody
Cat # A02420-1

Two the supplier anti-NR2F2 antibodies are listed for Western blot, both with reported human, mouse, and rat reactivity and WB images. The supplied caption for A02420-1 does not identify its tested samples or antibody dilution.

Which to pick: Choose A02420T7 when its documented conditions fit your experiment: a 1:500 dilution with MCF-7, HEK293T, H9C2, and MEF whole-cell lysates. A02420-1 also has a WB image, but the supplied description gives less detail for planning.

Source: BosterBio NR2F2 gene-info card — filtered to Western-blot-capable antibodies; each card shows that product's actual WB validation figure.